TS
Tej Pratap Singh
University of Pennsylvania, GlaxoSmithKline (United States), Medical University of Graz, National Institute of Allergy and Infectious Diseases
Employment
-
University of Pennsylvania2024 - Present
-
GlaxoSmithKline (United States)2023 - 2024
-
University of Pennsylvania2019 - 2023
-
National Institute of Allergy and Infectious Diseases Research Fellow2016 - 2019
-
National Institute of Allergy and Infectious Diseases Postdoctoral Fellow2011 - 2016
-
Medical University of Graz Postdoctoral Fellow2010 - 2011
-
Medical University of Graz Research Employee2007 - 2011
-
National Institute of Malaria Research Senior Research Fellow2006 - 2007
-
Institute of Genomics and Integrative Biology CSIR Project Research Fellow2004 - 2006
Education
-
Medical University of Graz PhD2007 - 2010
Projects & Funding
Projects & funding information is unavailable.
Publications (36)
- Multiomic profiling of cutaneous leishmaniasis infections reveals microbiota-driven mechanisms underlying disease severity. Save
- Regulatory T cells control Staphylococcus aureus and disease severity of cutaneous leishmaniasis Save
- The skin microbiome enhances disease through IL-1b and delays healing in cutaneous leishmaniasis patients Save
- Human CCR6+ Th Cells Show Both an Extended Stable Gradient of Th17 Activity and Imprinted Plasticity. Save
- Editorial: Microbiota in skin inflammatory diseases. Save
- Microbiota instruct IL-17A-producing innate lymphoid cells to promote skin inflammation in cutaneous leishmaniasis. Save
- IL-23- and Imiquimod-Induced Models of Experimental Psoriasis in Mice Save
- C/EBPδ drives interactions between human MAIT cells and endothelial cells that are important for extravasation Save
- Cbl-b deficiency provides protection against UVB-induced skin damage by modulating inflammatory gene signature Save
- Monocyte-derived inflammatory Langerhans cells and dermal dendritic cells mediate psoriasis-like inflammation Save